Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) [Phase 2]
Phase 2 clinical trial update for PUL-042 in patients with parainfluenza virus, human metapneumovirus, or respiratory syncytial virus infect…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease. [Phase 3]
Pfizer's RSVpreF Phase 3 study aims to evaluate safety and immune response in adults at high risk for severe Respiratory Syncytial Virus inf…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease [Phase 3]
Phase 3 clinical trial update for a vaccine against respiratory syncytial virus being tested in Chinese adults at increased risk, currently …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease [NA]
AstraZeneca is evaluating palivizumab for prevention of severe respiratory syncytial virus disease in high-risk children. The study is curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults [Phase 1]
This document describes a Phase 1 clinical trial to assess the safety and immunogenicity of the IN006 respiratory syncytial virus vaccine in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: RSV Vaccination to Reduce Recurrent AECOPD [Phase 4]
A Phase 4 clinical trial led by the Chinese University of Hong Kong is evaluating an RSV vaccine to reduce recurrent acute exacerbations of …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age [Phase 1]
A Phase 1 clinical trial in adults 18-49 is evaluating two vaccine formulations encoding the RSV monovalent antigen or the influenza A(H5) a…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children [Phase 3]
A Phase III clinical trial is evaluating deuremidevir hydrobromide for treating respiratory syncytial virus infection in infants and young c…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Risk Factors and Severity of Bronchiolitis in Hospitalized Children at Assiut University Hospital
A clinical trial sponsored by Assiut University is examining risk factors and severity of bronchiolitis in hospitalized children. The study …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease [Phase 2]
A Phase 2 study evaluating S-337395 for respiratory syncytial virus in symptomatic nonhospitalized adults at high risk of progression to sev…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women [Phase 1]
Phase 1 study evaluating safety, tolerability, and immunogenicity of MKK900, a maternal respiratory syncytial virus vaccine, in healthy adul…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus [Phase 2]
This is a Phase 2 clinical trial to evaluate the efficacy and safety of Zelicapavir in participants aged 28 days to 36 months with Respirato…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: RSV Burden in Outpatient and Hospital Settings [NA]
A pediatric clinical trial is currently recruiting to assess the burden of respiratory syncytial virus infection in outpatient and hospital …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose [Phase 3]
Pfizer is conducting a Phase 3 trial to evaluate revaccination in subsequent pregnancies using a bivalent RSV vaccine and to determine how l…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy [Phase 4]
Phase 4 clinical trial evaluating concurrent versus sequential administration of Tdap and an RSV vaccine in pregnant individuals.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: TARSILA Real-World Evidence Study
The TARSILA real-world evidence study sponsored by Inova Medical is not yet recruiting, investigating respiratory syncytial virus infection …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals [Phase 2]
This entry outlines a Phase 2 clinical trial evaluating remdesivir for upper respiratory tract infection due to respiratory syncytial virus …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine [Phase 1]
A Phase 1 clinical trial is evaluating the safety of a lyophilized RSV mRNA vaccine, sponsored by Sinovac Biotech, which is not yet recruiti…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants
A clinical trial registry entry describing a research study on the relationship between the gut microbiome and immune response in severe Res…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
VA-sponsored clinical trial update indicates ongoing recruitment to evaluate clinical outcomes and pharmacotherapy effectiveness. The study …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers [Phase 2]
Phase 2 clinical trial update for Moderna's mRNA-1345 RSV vaccine given to pregnant women and infants of vaccinated mothers; the study is ac…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER
Pfizer's RSV vaccine Abrysvo is being studied in adults aged 60 and older, and the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. [Phase 3]
Pfizer's Phase 3 study evaluating the RSVpreF vaccine for efficacy, immunogenicity, and safety in adults with lower respiratory tract illnes…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants [Phase 1, Phase 2]
Phase Ib/IIa trial evaluating SIBP-A16 Injection in premature and full-term infants for respiratory syncytial virus infection; the study is …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Systems Biological Analysis of Immune Responses to RSV Vaccine [Phase 4]
A Phase 4 clinical trial is studying systems biological analyses of immune responses to an RSV vaccine, with the study currently ACTIVE_NOT_…